EP Patent

EP1245247A1 — Biocidal locks

Assigned to ND Partners LLC · Expires 2002-10-02 · 24y expired

What this patent protects

Disclosed herein is an internal prosthetic device comprising: (a) means for providing a continuous flowpath, crossing a patient's skin, between an external-to-patient site and an internal-to-patient site; (b) means for blocking the flowpath; and (c) a biocidal lock compris…

USPTO Abstract

Disclosed herein is an internal prosthetic device comprising: (a) means for providing a continuous flowpath, crossing a patient's skin, between an external-to-patient site and an internal-to-patient site; (b) means for blocking the flowpath; and (c) a biocidal lock comprising: (i) an anticoagulant; and (ii) a non-antibiotic biocide.

Drugs covered by this patent

Patent Metadata

Patent number
EP1245247A1
Jurisdiction
EP
Classification
—
Expires
2002-10-02
Drug substance claim
No
Drug product claim
No
Assignee
ND Partners LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.